Thought Leadership
The Center for Biosimilars Interview Series: Legal Perspectives in Biosimilars
December 27, 2021
The Center for Biosimilars

Axinn partner Chad Landmon participated in a four-part video interview with Tony Hagen of The Center for Biosimilars. They discussed California’s “Pay-for-Delay” Law, the FDA's unique offer of assistance to the Patent and Trademark Office in reviewing patent applications, the potential impact of the Build Back Better Act on the biosimilars industry, and the FDA defining interchangeable biosimilars. Click below to access the interviews.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.